Videos de Experimentos Relacionados
Estudio de protección cardíaca Estudio de protección cardíaca.
Lancet (London, England)
|February 14, 2003
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Societal Versus Healthcare Perspectives on the Cost Effectiveness of Ocrelizumab for Treatment of Primary Progressive Multiple Sclerosis in Aotearoa New Zealand.
PharmacoEconomics·2025
Same author
Hospital Cost Savings for Sequential COPD Patients Receiving Domiciliary Nasal High Flow Therapy.
International journal of chronic obstructive pulmonary disease·2022
Same author
GA4GH: International policies and standards for data sharing across genomic research and healthcare.
Cell genomics·2022
Same author
Impact of age, sex, ethnicity, socio-economic deprivation and novel pharmaceuticals on the overall survival of patients with multiple myeloma in New Zealand.
British journal of haematology·2019
Same author
Primary prevention of rheumatic fever in the 21st century: evaluation of a national programme.
International journal of epidemiology·2018
Same author
Hospital admissions for chronic obstructive pulmonary disease in New Zealand.
The New Zealand medical journal·2015
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026